NCT01537614

Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 7 (actual)
• Sponsor: Poitiers University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Pharmacokinetics of colimycin will be assessed during 12 hours after administration of 2M UI colimycin either as an aerosol or after IV injection, the administration being separated by 5 to 10 days intervals

Conditions

• Cystic Fibrosis

Interventions

Type	Name	Description
DRUG	COLIMYCINE inhalation	2 MILLION UI
DRUG	COLIMYCINE injectable	2 MILLIONS UI

Timeline

• Start date: 2011-10-01
• Primary completion: 2013-02-01
• First posted: 2012-02-23
• Last updated: 2016-10-11

Locations

1 site across 1 country: France